Lifekind completes Refinancing to support growth initiatives
Overview
| Deal Type |
Debt Capital Markets |
|---|---|
| Size |
$20 Million Senior Secured Credit Facilities |
| Client & Transactional Partners |
Lifekind |
| Our Role |
Sole Lead Arranger Sole Bookrunner Administrative Agent |
Summary
KeyBanc Capital Markets and Cain Brothers, a division of KeyBanc Capital Markets, successfully closed the syndication of $20 million Senior Secured Credit Facilities for Lifekind (formerly known as SAVAS Health).
The Credit Facilities are comprised of a Revolving Credit Facility, Term Loan and Delayed Draw Term Loan. Proceeds will be used to refinance existing indebtedness, provide a distribution to shareholders and support near-term strategic growth initiatives. KBCM served as Sole Lead Arranger, Sole Bookrunner, and Administrative Agent on the Credit Facilities due to Cain Brothers’ industry expertise and long-term relationship with the Company and its founder.
Lifekind is a tech-enabled company specializing in innovative, value-based care models for complex chronic conditions, including chronic neck and back pain, neuropathic pain, arthritis, or more complex conditions such as fibromyalgia, cancer and post-surgical pain. The Company delivers holistic, patient-centered care through its proprietary program, which integrates behavioral health, physical reconditioning, and alternative therapies. Lifekind also operates ambulatory surgical centers and employs a proprietary software platform to enhance care delivery, improve patient outcomes, and optimize operational efficiency.
Ryan Stilphen
KeyBanc Capital Markets Inc., Member FINRA/SIPC, and KeyBank National Association ("KeyBank N.A.") are separate, but affiliated companies. Securities products and services are offered by KeyBanc Capital Markets Inc. and its licensed securities representatives.
Securities products and services: Not FDIC Insured • No Bank Guarantee • May Lose Value
Banking products and services are offered by KeyBank N.A. All credit, loan, and leasing products are subject to collateral and/or credit approval terms, conditions, and availability and subject to change.











































